Sep 03, 2025
Nanalysis Chosen by IMRIS as Critical Component MRI Supplier
Aug 28, 2025
Nanalysis Announces Second Quarter 2025 Results
Aug 21, 2025
Nanalysis Announces Second Quarter 2025 Conference Call
Jul 09, 2025
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro)
May 28, 2025
Nanalysis Announces First Quarter 2025 Results
May 15, 2025
Nanalysis Announces First Quarter 2025 Conference Call
Apr 24, 2025
Nanalysis Announces Fourth Quarter and Full Year 2024 Results
Apr 17, 2025
Nanalysis Announces Fourth Quarter and Full Year 2024 Conference Call
Mar 18, 2025
Nanalysis Announces Release of Automation Software
Mar 05, 2025
Nanalysis Announces Next Generation 60MHz Benchtop NMR Spectrometer
Feb 27, 2025
Nanalysis Provides Fourth Quarter Preview (Unaudited)
Dec 11, 2024
Nanalysis and The United States Pharmacopeia (USP) Co-Publish Study Demonstrating Efficacy of Benchtop NMR for Quality Control
Nov 21, 2024
Nanalysis Announces Third Quarter 2024 Results
Nov 07, 2024
Nanalysis Announces Third Quarter 2024 Conference Call
Oct 15, 2024
Nanalysis to Present at the LD Micro Main Event XVII
Aug 28, 2024
Nanalysis Announces Second Quarter 2024 Results
Aug 14, 2024
Nanalysis Announces Second Quarter 2024 Conference Call
Jun 28, 2024
Nanalysis Announces New Director and Results of AGM
Jun 07, 2024
Nanalysis Announces Grant of Stock Options
May 29, 2024
Nanalysis Announces First Quarter 2024 Results